Cargando…
Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis
Onconeural antibodies are associated with cancer and paraneoplastic encephalitis. While their pathogenic role is still largely unknown, their high diagnostic value is undisputed. In this study we describe the discovery of a novel target of autoimmunity in an index case of paraneoplastic encephalitis...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448146/ https://www.ncbi.nlm.nih.gov/pubmed/28554330 http://dx.doi.org/10.1186/s40478-017-0447-3 |
_version_ | 1783239512161255424 |
---|---|
author | Popkirov, Stoyan Ayzenberg, Ilya Hahn, Stefanie Bauer, Jan Denno, Yvonne Rieckhoff, Nicole Radzimski, Christiane Hans, Volkmar H. Berg, Sebastian Roghmann, Florian Noldus, Joachim Bien, Christian G. Skodda, Sabine Wellmer, Jörg Stöcker, Winfried Krogias, Christos Gold, Ralf Schlegel, Uwe Probst, Christian Komorowski, Lars Miske, Ramona Kleiter, Ingo |
author_facet | Popkirov, Stoyan Ayzenberg, Ilya Hahn, Stefanie Bauer, Jan Denno, Yvonne Rieckhoff, Nicole Radzimski, Christiane Hans, Volkmar H. Berg, Sebastian Roghmann, Florian Noldus, Joachim Bien, Christian G. Skodda, Sabine Wellmer, Jörg Stöcker, Winfried Krogias, Christos Gold, Ralf Schlegel, Uwe Probst, Christian Komorowski, Lars Miske, Ramona Kleiter, Ingo |
author_sort | Popkirov, Stoyan |
collection | PubMed |
description | Onconeural antibodies are associated with cancer and paraneoplastic encephalitis. While their pathogenic role is still largely unknown, their high diagnostic value is undisputed. In this study we describe the discovery of a novel target of autoimmunity in an index case of paraneoplastic encephalitis associated with urogenital cancer. A 75-year-old man with a history of invasive bladder carcinoma 6 years ago with multiple recurrences and a newly discovered renal cell carcinoma presented with seizures and progressive cognitive decline followed by super-refractory status epilepticus. Clinical and ancillary findings including brain biopsy suggested paraneoplastic encephalitis. Immunohistochemistry of the brain biopsy was used to characterize the inflammatory response. Indirect immunofluorescence assay (IFA) was used for autoantibody screening. The autoantigen was identified by histo-immunoprecipitation and mass spectrometry and was validated by expressing the recombinant antigen in HEK293 cells and neutralization tests. Sera from 125 control patients were screened using IFA to test for the novel autoantibodies. IFA analysis of serum revealed a novel autoantibody against brain tissue. An intracellular enzyme, Rho-associated protein kinase 2 (ROCK2), was identified as target-antigen. ROCK2 was expressed in affected brain tissue and archival bladder tumor samples of this patient. Brain histopathology revealed appositions of cytotoxic CD8(+) T cells on ROCK2-positive neurons. ROCK2 antibodies were not found in the sera of 20 patients with bladder cancer and 17 with renal cancer, both without neurological symptoms, 49 healthy controls, and 39 patients with other antineuronal autoantibodies. In conclusion, novel onconeural antibodies targeting ROCK2 are associated with paraneoplastic encephalitis and should be screened for when paraneoplastic neurological syndromes, especially in patients with urogenital cancers, occur. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0447-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5448146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54481462017-05-30 Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis Popkirov, Stoyan Ayzenberg, Ilya Hahn, Stefanie Bauer, Jan Denno, Yvonne Rieckhoff, Nicole Radzimski, Christiane Hans, Volkmar H. Berg, Sebastian Roghmann, Florian Noldus, Joachim Bien, Christian G. Skodda, Sabine Wellmer, Jörg Stöcker, Winfried Krogias, Christos Gold, Ralf Schlegel, Uwe Probst, Christian Komorowski, Lars Miske, Ramona Kleiter, Ingo Acta Neuropathol Commun Research Onconeural antibodies are associated with cancer and paraneoplastic encephalitis. While their pathogenic role is still largely unknown, their high diagnostic value is undisputed. In this study we describe the discovery of a novel target of autoimmunity in an index case of paraneoplastic encephalitis associated with urogenital cancer. A 75-year-old man with a history of invasive bladder carcinoma 6 years ago with multiple recurrences and a newly discovered renal cell carcinoma presented with seizures and progressive cognitive decline followed by super-refractory status epilepticus. Clinical and ancillary findings including brain biopsy suggested paraneoplastic encephalitis. Immunohistochemistry of the brain biopsy was used to characterize the inflammatory response. Indirect immunofluorescence assay (IFA) was used for autoantibody screening. The autoantigen was identified by histo-immunoprecipitation and mass spectrometry and was validated by expressing the recombinant antigen in HEK293 cells and neutralization tests. Sera from 125 control patients were screened using IFA to test for the novel autoantibodies. IFA analysis of serum revealed a novel autoantibody against brain tissue. An intracellular enzyme, Rho-associated protein kinase 2 (ROCK2), was identified as target-antigen. ROCK2 was expressed in affected brain tissue and archival bladder tumor samples of this patient. Brain histopathology revealed appositions of cytotoxic CD8(+) T cells on ROCK2-positive neurons. ROCK2 antibodies were not found in the sera of 20 patients with bladder cancer and 17 with renal cancer, both without neurological symptoms, 49 healthy controls, and 39 patients with other antineuronal autoantibodies. In conclusion, novel onconeural antibodies targeting ROCK2 are associated with paraneoplastic encephalitis and should be screened for when paraneoplastic neurological syndromes, especially in patients with urogenital cancers, occur. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0447-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-29 /pmc/articles/PMC5448146/ /pubmed/28554330 http://dx.doi.org/10.1186/s40478-017-0447-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Popkirov, Stoyan Ayzenberg, Ilya Hahn, Stefanie Bauer, Jan Denno, Yvonne Rieckhoff, Nicole Radzimski, Christiane Hans, Volkmar H. Berg, Sebastian Roghmann, Florian Noldus, Joachim Bien, Christian G. Skodda, Sabine Wellmer, Jörg Stöcker, Winfried Krogias, Christos Gold, Ralf Schlegel, Uwe Probst, Christian Komorowski, Lars Miske, Ramona Kleiter, Ingo Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis |
title | Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis |
title_full | Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis |
title_fullStr | Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis |
title_full_unstemmed | Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis |
title_short | Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis |
title_sort | rho-associated protein kinase 2 (rock2): a new target of autoimmunity in paraneoplastic encephalitis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448146/ https://www.ncbi.nlm.nih.gov/pubmed/28554330 http://dx.doi.org/10.1186/s40478-017-0447-3 |
work_keys_str_mv | AT popkirovstoyan rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT ayzenbergilya rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT hahnstefanie rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT bauerjan rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT dennoyvonne rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT rieckhoffnicole rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT radzimskichristiane rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT hansvolkmarh rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT bergsebastian rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT roghmannflorian rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT noldusjoachim rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT bienchristiang rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT skoddasabine rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT wellmerjorg rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT stockerwinfried rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT krogiaschristos rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT goldralf rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT schlegeluwe rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT probstchristian rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT komorowskilars rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT miskeramona rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis AT kleiteringo rhoassociatedproteinkinase2rock2anewtargetofautoimmunityinparaneoplasticencephalitis |